Research activity

Here is a list of all the research activity pages:

Generic List


AdUP: A Phase I Clinical Trial of a replication defective type 5 adenovirus vector expressing nitroreductase and GMCSF (AdNRGM) given via trans-perineal, template-guided, intra-prostatic injection, followed by intravenous CB1954, in patients with locally relapsed Prostate Cancer.

Advanced Manufacturing Technology Centre - Mechanical Engineering research

The Advanced Manufacturing Technology Centre brings together key research groups and individuals within the University of Birmingham's School of Mechanical Engineering. It includes: Advanced Machining, Automation and Intelligent Manufacturing, Laser processing, Micro Manufacturing and Computer Aided Engineering.

Africa hub

The Africa Hub (AHub) promotes and disseminates Africa-focused research conducted across Colleges and Departments at the University of Birmingham, and in collaboration with Birmingham's academics. Its goal is to spread innovative ideas, question stereotypes, and integrate findings from African Studies into a broad range of academic fields and public debates.

Aggressive Research Intelligence Facility (ARIF)

ARIF was a specialist unit based at the University of Birmingham whose role was to improve the incorporation of research findings into population level health care decisions in the NHS in the West Midlands.In 2011, ARIF was succeeded by the West Midlands Commissioning Support UnitThe ARIF Databases and Systematically Speaking bulletins are being updated and these, as well as completed ARIF requests are still available.

An exploration of mental health blogging

Homepage for a research study to explore people's experiences of writing personal journal style blogs, which mainly focus on expression of thoughts and emotions, encompassing experiences of mental health difficulties.

Angiogenesis Research Group

Information on the Angiogenesis Group led by Professor Roy Bicknell and Dr Victoria Heath, at the University of Birmingham.

Angioplasty and Stent for Renal Artery Lesions trial (ASTRAL)

ASTRAL is a multicentre, randomized, unblinded clinical trial, comparing revascularisation in addition to medical therapy versus medical therapy alone in patients with atherosclerotic renovascular disease (ARVD). The aim of ASTRAL is to assess whether renal arterial revascularisation with balloon angioplasty and/or endovascular stenting can safely prevent progressive renal failure among patients with ARVD. ASTRAL closed to recruitment in October 2007 having recruited 806 patients, and is now in long term follow up until 2017. The trial is managed by the BCTU at the University of Birmingham.
Displaying 11 to 20 of 721
Previous 1 2 3 4 5 Next